Technology News and Research

RSS

Biodesix awarded US patent for VeriStrat serum test

Biodesix, Inc., a company developing and commercializing molecular diagnostics for personalized medicine, announced today that the United States Patent and Trademark Office has awarded to the Company patent number 7,736,905. The patent provides coverage for the Company's first product, VeriStrat®, which is used by physicians to help guide therapy for patients with advanced lung cancer. The allowed claims are directed towards the serum-based identification of patients likely to benefit from epidermal growth factor targeted therapy.

22 Jun 2010

TransGenRx to produce protein-based therapeutics to support Esperion's research on HDL therapies

Esperion Therapeutics, a privately held biopharmaceutical company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced that TransGenRx, a global leader in transgenic technology, will produce protein-based therapeutics to be used in the company's research efforts targeting HDL therapies for the treatment of cardio-metabolic disease.

22 Jun 2010

Biotage launches ISOLUTE SLE+ sample preparation columns

Biotage, a leading supplier of tools and technology for medicinal and analytical chemistry, announced the introduction of ISOLUTE SLE+ High-Performance Supported Liquid Extraction sample preparation columns. The announcement occurred during the 58th ASMS Conference on Mass Spectrometry and Allied Topics in Salt Lake City, Utah USA.

22 Jun 2010

NTU, Technion announce new collaboration to jointly offer PhD programme

Singapore's leading science and technology university, Nanyang Technological University, and Israel's number one university, Technion-Israel Institute of Technology, today announced a new collaboration to jointly offer a Doctor of Philosophy programme.

22 Jun 2010

Patients are seeking self-service convenience to manage healthcare expenses: NCR survey

The latest survey of U.S. consumers, commissioned by NCR Corporation, shows that patients are increasingly seeking self-service convenience when managing the financial aspects of their healthcare experience. The annual consumer study, conducted by Buzzback Market Research, reveals that more than half (51 percent) of respondents would like to manage their healthcare account by viewing payment history and settling outstanding balances via online and mobile channels.

22 Jun 2010

Research article sheds light on liability concerns and electronic health records systems

Electronic health record systems likely will soon become a fixture in medical settings. Advocates claim they will reduce health care costs and improve medical outcomes, which could be critical since the new health care reform law increases access for millions of Americans. Although benefits of bringing information technology to health records can be substantial, EHR systems also give rise to increased liability risks for health care providers due to possible software or hardware problems or user errors.

22 Jun 2010

Star Scientific seeks FDA approval of Stonewall-BDL as "modified risk tobacco product"

Star Scientific, Inc. announced that on Friday, June 18 the company filed an application with the Food & Drug Administration for approval to market Stonewall-BDL™ as a "modified risk tobacco product" under the Family Smoking Prevention and Tobacco Control Act of 2009. This is Star's second such application to the Tobacco Products Center of the FDA, which has been established to oversee all aspects of tobacco regulation outlined in the 2009 Act.

22 Jun 2010

FDA grants approval for newest version of OnGuard Chest X-ray CAD technology

Riverain Medical announced today that the U.S. Food and Drug Administration has granted approval for the newest version of the OnGuard Chest X-ray Computer-Aided Detection technology. OnGuard identifies solitary pulmonary nodules that may represent early-stage lung cancer on an existing chest X-ray. This improved performance demonstrates a 73% reduction in false positive marks and 50% higher relative sensitivity compared to the original product.

22 Jun 2010

Discoveries in study and manipulation of human ES cells win first prize in research competition

World-recognized discoveries in the study and manipulation of human embryonic stem cells have won first prize in a prestigious applied research competition for a Hebrew University of Jerusalem researcher.

22 Jun 2010

USAID Administrator shares vision for agency reform

During a speech at the National Press Club on Friday, USAID Administrator Rajiv spoke about ongoing efforts to reform the agency he oversees, noting the importance of improving development strategies targeting women, among other things, All Headline News reports (6/20).

22 Jun 2010

PPC Canada announces alliance with LifeSpeak

PPC Canada is pleased to announce an alliance with LifeSpeak Inc., designed to help customer employees across Canada work, learn and thrive. The addition of LifeSpeak's online, expert-led video clips to PPC Canada's current suite of offerings will provide employees with a just-in-time learning tool integrated into their Employee Assistance Program.

22 Jun 2010

EPA honors Merck and Codexis with Presidential Green Chemistry Challenge Award

Merck and Codexis, Inc. today announced that they have jointly been awarded the annual Presidential Green Chemistry Challenge Award from the U.S. Environmental Protection Agency for the development of a novel biocatalytic method for the synthesis of sitagliptin. In addition, a paper co-authored by Merck and Codexis scientists and published online June 17 in the peer-reviewed journal Science, details how an enzyme was systematically customized using Codexis technology to perform the key chemical step in the sitagliptin synthesis process.

22 Jun 2010

Cernostics, Geisinger announce personalized healthcare collaboration

Cernostics Inc., a biotechnology firm specializing in advanced cancer diagnostics, and Geisinger Health System, a $2.1 billion integrated health services organization, today announced a partnership in personalized healthcare. They will focus on developing diagnostic technologies to detect subtle differences in the cellular and molecular makeup of patient tissue samples. These technologies promise to more effectively predict disease progression and identify patients who are most likely to be receptive to specific cancer treatments.

22 Jun 2010

Celator announces expansion of research agreement with Cephalon

Celator Pharmaceuticals today announced that it has expanded its research agreement with Cephalon, Inc.. The research agreement provides for the utilization of Celator's proprietary technology in an ongoing drug development and life-cycle management program at Cephalon.

22 Jun 2010

Incline acquires IONSYS, announces $43 million Series A financing

Incline Therapeutics, Inc., a privately-held, hospital-focused specialty pharmaceutical company, announced today that it has entered into an agreement to acquire the rights to IONSYS™ (fentanyl iontophoretic transdermal system) from ALZA Corporation and completed a $43 million Series A financing.

22 Jun 2010

Congressional hearing examines administration's crack down on health care fraud

The feds have promised to turn up the heat on providers, real and phony, who steal from and game the system. ... Lawmakers and President Barack Obama are demanding that the CMS and their partners in law enforcement do more to stem the wasted healthcare dollars gushing out of the Treasury like oil into the Gulf of Mexico.

22 Jun 2010

Reform law gives major boost to community health centers, medical homes

The Washington Post: "The health-care legislation signed into law in March provides a major boost to community health centers: $11 billion over five years. The first of these federally supported primary-care clinics opened in 1965." The law also provides funding designed to increase the supply of primary-care providers. And, "[o]n Wednesday, Secretary of Health and Human Services Kathleen Sebelius announced that the federal government will spend $250 million in programs to increase the number of doctors, nurses and other care providers.

21 Jun 2010

Angeion launches new TRUcal resting metabolic rate system

Angeion Corporation announced that it has launched its new TRUcal™ resting metabolic rate system. Part of its New Leaf® product line, TRUcal includes an analyzer that gently measures one's breath for oxygen and carbon dioxide which gives consumers their true individualized daily calories their body requires. The TRUcal™ system also includes a compact netbook with Bluetooth® technology, adding the benefit of wireless connectivity.

21 Jun 2010

Millar, Telemetry Research partner to offer TRM53P implantable transmitters

Millar Instruments, Inc., a medical device manufacturing firm and developer of pressure sensing technology, has released the TRM53P implantable transmitter through the partnership with Telemetry Research, Ltd. The TRM53P is the world's first, fully implantable transmitter that combines Millar's gold standard solid-state pressure sensors with Telemetry Research's next generation telemetry technology.

21 Jun 2010

CareGroup Healthcare System to implement InterSystems Ensemble rapid integration, development platform

InterSystems Corporation, the global leader in software for connected healthcare, today announced that CareGroup Healthcare System, a Boston-based integrated delivery network (IDN) comprised of four hospitals, has selected the InterSystems Ensemble® rapid integration and development platform to replace its legacy eGate platform for strategic integration throughout the organization.

21 Jun 2010